Pharmacology, Toxicology and Pharmaceutical Science
Atrial Fibrillation
77%
Drug Utilization
62%
Cerebrovascular Accident
53%
Case-Control Study
40%
Malignant Neoplasm
40%
Overactive Bladder
38%
Antivitamin K
38%
Anticoagulant Agent
38%
Mirabegron
38%
Randomized Clinical Trial
38%
Beta Adrenergic Receptor Blocking Agent
30%
Cohort Study
27%
Placebo
21%
Clinical Trial
21%
Brain Ischemia
21%
Defined Daily Dose
21%
Prevalence
19%
Quetiapine
19%
Brain Natriuretic Peptide
19%
Observational Study
19%
Community Pharmacy
19%
Breast Cancer
19%
Upper Gastrointestinal Bleeding
19%
Cardiovascular Risk
19%
Dicloxacillin
19%
Antithrombocytic Agent
19%
Dipeptidyl Carboxypeptidase Inhibitor
19%
Warfarin
19%
Lip Cancer
19%
Statin (Protein)
19%
COVID-19 Vaccine
19%
Chronic Obstructive Lung Disease
19%
Hydrochlorothiazide
19%
Aclidinium Bromide
19%
Formoterol
19%
Flucloxacillin
19%
Congestive Heart Failure
19%
Morphine
19%
Oxycodone
19%
Prescription Drug
19%
Paclitaxel
19%
Atorvastatin
19%
Neurotoxicity
19%
Gabapentinoid
19%
Cardiovascular Mortality
14%
Angiotensin Receptor Antagonist
11%
Aldosterone Antagonist
11%
All Cause Mortality
11%
Dabigatran
9%
Squamous Cell Carcinoma
9%
Medicine and Dentistry
Atrial Fibrillation
100%
Apoplexy
88%
Implantable Loop Recorder
36%
Hazard Ratio
30%
Vitamin K Antagonist
22%
Post-Hoc Analysis
20%
Brain Natriuretic Peptide
19%
Amino Terminal Sequence
19%
Direct Oral Anticoagulant
19%
Malignant Neoplasm
19%
Observational Study
19%
Bleeding
19%
Overactive Bladder
19%
General Practitioner
19%
Retrospective Cohort Study
19%
Antithrombotic
19%
Mirabegron
19%
COVID-19 Vaccine
19%
Thyroid Function
19%
Thyrotropin
19%
Lip Cancer
19%
P Wave
19%
Gadolinium
19%
Hydrochlorothiazide
19%
Gabapentinoid
19%
Squamous Cell Carcinoma
9%
Cerebral Hemorrhage
9%
Cardiovascular System
8%
Major Bleeding
7%
Acetylsalicylic Acid
6%
Interatrial Block
6%
Odds Ratio
5%
Gabapentin
5%
Pregabalin
5%
Ciclonicate
5%